OppenheimerFunds’s Halozyme HALO Stock Holding History

OppenheimerFunds’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$16.1M	Hold	1,000,000	–	–	0.02%	587
2018 Q4	$14.6M	Hold	1,000,000	–	–	0.02%	583
2018 Q3	$18.2M	Hold	1,000,000	–	–	0.02%	610
2018 Q2	$16.9M	Sell	1,000,000 -381	-0%	-$7.2K	0.02%	621
2018 Q1	$19.6M	Sell	1,000,381 -1,934	-0.2%	-$37.5K	0.02%	573
2017 Q4	$20.3M	Sell	1,002,315 -178	-0%	-$3.27K	0.02%	577
2017 Q3	$17.4M	Sell	1,002,493 -271	-0%	-$3.67K	0.02%	614
2017 Q2	$12.9M	Buy	1,002,764 +588	+0.1%	+$7.85K	0.02%	692
2017 Q1	$13M	Buy	1,002,176 +2,176	+0.2%	+$27.5K	0.02%	708
2016 Q4	$9.88M	Hold	1,000,000	–	–	0.01%	758
2016 Q3	$12.1M	Hold	1,000,000	–	–	0.02%	697
2016 Q2	$8.63M	Hold	1,000,000	–	–	0.01%	745
2016 Q1	$9.47M	Hold	1,000,000	–	–	0.01%	735
2015 Q4	$17.3M	Hold	1,000,000	–	–	0.02%	614
2015 Q3	$13.4M	Hold	1,000,000	–	–	0.02%	655
2015 Q2	$22.6M	Hold	1,000,000	–	–	0.03%	552
2015 Q1	$14.3M	Hold	1,000,000	–	–	0.02%	678
2014 Q4	$9.65M	Hold	1,000,000	–	–	0.01%	770
2014 Q3	$9.1M	Buy	+1,000,000	New	+$9.52M	0.01%	759

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

OppenheimerFunds's HALO Position: Q1 2019 in Review

OppenheimerFunds held its Halozyme (HALO) position steady in Q1 2019 at 1,000,000 shares worth $16.1M. The position accounts for 0.02% of the portfolio, ranked #587.

OppenheimerFunds first reported a position in HALO in Q3 2014 and has held it in 19 quarters since. The position peaked at $22.6M in Q2 2015. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

OppenheimerFunds held 1,000,000 shares of Halozyme worth $16.1M as of Q1 2019.
OppenheimerFunds left its Halozyme share count unchanged in Q1 2019.
Halozyme made up 0.02% of OppenheimerFunds's portfolio in Q1 2019, its #587 holding.
OppenheimerFunds first reported a position in Halozyme in Q3 2014 and has held it in 19 quarters since.
OppenheimerFunds's Halozyme position peaked at $22.6M in Q2 2015.
201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.